Furthermore, CBR-470-1-induced mRNA and proteins appearance of Nrf2 pathway genes, and mRNA in stable SH-SY5Y neuronal cells with Nrf2 shRNA (sh-Nrf2) or a lenti-CRISPR/Cas9-Nrf2 KO construct (ko-Nrf2), as well as in the parental control cells (Pare), was shown (A); Cells were treated with CBR-470-1 (CBR, 10 M) or the vehicle control (Veh) for applied time periods, expression of outlined mRNAs and proteins was shown (BCD); Alternatively, cells were pre-treated for 2h with CBR-470-1 (CBR, 10 M) or the vehicle control (Veh), followed by MPP+ (3 mM) activation for 48h, cell viability and death were tested by CCK-8 (E) and medium LDH release (F) assays, respectively
Furthermore, CBR-470-1-induced mRNA and proteins appearance of Nrf2 pathway genes, and mRNA in stable SH-SY5Y neuronal cells with Nrf2 shRNA (sh-Nrf2) or a lenti-CRISPR/Cas9-Nrf2 KO construct (ko-Nrf2), as well as…